Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhuhai Laichi Medical Beauty Technology is a Chinese medical aesthetics company specializing in the research, development, and distribution of innovative aesthetic materials and digital imaging equipment. The company is best known as the national general agent for the Transplus (Chao Ti) brand of nasal implants, which utilize a unique 3D micro-pore technology to improve biocompatibility and aesthetic results in rhinoplasty. Beyond surgical implants, Laichi provides the Yizhipai facial imaging analyzer to assist clinicians in patient consultation and treatment planning. The company is also advancing a pharmaceutical pipeline, including a topical Lidocaine/Prilocaine cream currently in the bioequivalence study stage for local anesthesia. Headquartered in Zhuhai, Laichi is a key player in the light medical beauty sector, integrating advanced materials with digital health solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhuhai Laichi Medical Beauty Technology.